Surabi Biomedical Instrumentation India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -8.78%
- Profit Growth -26.82%
- Ebitda 559.26%
- Net Worth -723.90%
- Total Assets -38.09%
About Surabi Biomedical Instrumentation India
Surabi Biomedical Instrumentation India Private Limited (SBIIPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2003 and has a history of 21 years and 11 months. Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Indralekha Muthuswami, Angamuthu Muthuswami, and Muthuswami Ganesh serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U00331TZ2003PTC010493
-
Company No.
010493
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Surabi Biomedical Instrumentation India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthuswami Ganesh
|
Director | 24-Feb-2003 | Current |
|
Indralekha Muthuswami
|
Director | 24-Feb-2003 | Current |
|
Angamuthu Muthuswami
|
Director | 24-Feb-2003 | Current |
Financial Performance of Surabi Biomedical Instrumentation India.
Surabi Biomedical Instrumentation India Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.78% decrease. The company also saw a substantial fall in profitability, with a 26.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 723.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surabi Biomedical Instrumentation India?
In 2017, Surabi Biomedical Instrumentation India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Surabi Biomedical Instrumentation India?
Unlock and access historical data on people associated with Surabi Biomedical Instrumentation India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surabi Biomedical Instrumentation India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surabi Biomedical Instrumentation India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.